Plasma AR and abiraterone-resistant prostate cancer

AR gene aberrations are rare in prostate cancer prior to primary hormone treatment but emerge with castration resistance. To determine AR gene status using a minimally-invasive assay that could have broad clinical utility, we developed a targeted next-generation sequencing approach amenable to plasm...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Transl Med
Hlavní autoři: Romanel, Alessandro, Gasi Tandefelt, Delila, Conteduca, Vincenza, Jayaram, Anuradha, Casiraghi, Nicola, Wetterskog, Daniel, Salvi, Samanta, Amadori, Dino, Zafeiriou, Zafeiris, Rescigno, Pasquale, Bianchini, Diletta, Gurioli, Giorgia, Casadio, Valentina, Carreira, Suzanne, Goodall, Jane, Wingate, Anna, Ferraldeschi, Roberta, Tunariu, Nina, Flohr, Penny, De Giorgi, Ugo, de Bono, Johann S, Demichelis, Francesca, Attard, Gerhardt
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6112410/
https://ncbi.nlm.nih.gov/pubmed/26537258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aac9511
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky